Skip to main content

Advertisement

SpringerLink
Log in

Low-energy extracorporeal shock wave ameliorates ischemic acute kidney injury in rats

  • Original article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Low-energy extracorporeal shock wave (SW) improves ventricular function in ischemic cardiomyopathy through the upregulation of vascular endothelial growth factor (VEGF). VEGF is known to play important roles in acute kidney injury (AKI), and the present study investigates the efficacy of SW for AKI by renal ischemia–reperfusion (I/R) injury.

Methods

Male 8-week-old Sprague–Dawley rats were divided into the following groups: SW-treated I/R group (I/R-SW), untreated I/R group (I/R), and Sham group. To induce I/R, the left renal pedicles were clamped for 45 min. The I/R-SW group was treated with SW to both kidneys on the immediate postoperative period (day 0), days 1, 2, 7, 8, 9, 14, 15, and 16. Rats were killed on day 2 and day 20 to determine histology, renal function, and Vegf family mRNA expression.

Results

Plasma creatinine on day 2 was significantly lower in the I/R-SW group than in the I/R group. Light microscopy revealed significantly lower tubular injury scores for the outer medulla in the I/R-SW group than in the I/R group. Podoplanin-positive lymphatic vessels were significantly increased in the left (affected side) outer medulla in the I/R-SW group on day 20. The expression levels of Vegf in the right (intact side) cortex were significantly higher in the I/R-SW group than in the I/R group on day 2.

Conclusion

Shock wave ameliorated renal tubular injury and renal function in AKI model, through the stimulation of Vegf family expression and lymphangiogenesis. SW may be effective as a non-invasive treatment for ischemic AKI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Yasuda H, Kato A, Fujigaki Y, Hishida A, Shizuoka Kidney Disease Study G. Incidence and clinical outcomes of acute kidney injury requiring renal replacement therapy in Japan. Ther Apher Dial. 2010;14(6):541–6. https://doi.org/10.1111/j.1744-9987.2010.00826.x.

    Article  PubMed  Google Scholar 

  2. Schetz M, Gunst J, De Vlieger G, Van den Berghe G. Recovery from AKI in the critically ill: potential confounders in the evaluation. Intensive Care Med. 2015;41(9):1648–57. https://doi.org/10.1007/s00134-015-3946-3.

    Article  CAS  PubMed  Google Scholar 

  3. Chade AR. VEGF: potential therapy for renal regeneration. F1000. Med Rep. 2012;4:1. https://doi.org/10.3410/M4-1.

    Article  Google Scholar 

  4. Doi K, Noiri E, Fujita T. Role of vascular endothelial growth factor in kidney disease. Curr Vasc Pharmacol. 2010;8(1):122–8.

    Article  CAS  PubMed  Google Scholar 

  5. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation. 2004;110(19):3055–61. https://doi.org/10.1161/01.CIR.0000148849.51177.97.

    Article  PubMed  Google Scholar 

  6. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis. 2006;17(1):63–70.

    Article  PubMed  Google Scholar 

  7. Kikuchi Y, Ito K, Ito Y, Shiroto T, Tsuburaya R, Aizawa K, et al. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J. 2010;74(3):589–91.

    Article  PubMed  Google Scholar 

  8. Serizawa F, Ito K, Kawamura K, Tsuchida K, Hamada Y, Zukeran T, et al. Extracorporeal shock wave therapy improves the walking ability of patients with peripheral artery disease and intermittent claudication. Circ J. 2012;76(6):1486–93.

    Article  PubMed  Google Scholar 

  9. Abe Y, Ito K, Hao K, Shindo T, Ogata T, Kagaya Y, et al. Extracorporeal low-energy shock-wave therapy exerts anti-inflammatory effects in a rat model of acute myocardial infarction. Circ J. 2014;78(12):2915–25.

    Article  CAS  PubMed  Google Scholar 

  10. Ito Y, Ito K, Shiroto T, Tsuburaya R, Yi GJ, Takeda M, et al. Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo. Coron Artery Dis. 2010;21(5):304–11.

    Article  PubMed  Google Scholar 

  11. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis. 2007;18(5):397–404. https://doi.org/10.1097/MCA.0b013e328089f19b.

    Article  PubMed  Google Scholar 

  12. Serizawa F, Ito K, Matsubara M, Sato A, Shimokawa H, Satomi S. Extracorporeal shock wave therapy induces therapeutic lymphangiogenesis in a rat model of secondary lymphoedema. Eur J Vasc Endovasc Surg. 2011;42(2):254–60. https://doi.org/10.1016/j.ejvs.2011.02.029.

    Article  CAS  PubMed  Google Scholar 

  13. Yamaya S, Ozawa H, Kanno H, Kishimoto KN, Sekiguchi A, Tateda S, et al. Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury. J Neurosurg. 2014;121(6):1514–25. https://doi.org/10.3171/2014.8.JNS132562.

    Article  PubMed  Google Scholar 

  14. Gigliotti JC, Huang L, Ye H, Bajwa A, Chattrabhuti K, Lee S, et al. Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway. J Am Soc Nephrol. 2013;24(9):1451–60. https://doi.org/10.1681/asn.2013010084.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Gigliotti JC, Huang L, Bajwa A, Ye H, Mace EH, Hossack JA, et al. Ultrasound modulates the splenic neuroimmune axis in attenuating AKI. J Am Soc Nephrol. 2015;26(10):2470–81. https://doi.org/10.1681/asn.2014080769.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Roelofs JJ, Rouschop KM, Leemans JC, Claessen N, de Boer AM, Frederiks WM, et al. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol. 2006;17(1):131–40. https://doi.org/10.1681/ASN.2005010089.

    Article  CAS  PubMed  Google Scholar 

  17. Sakamoto I, Ito Y, Mizuno M, Suzuki Y, Sawai A, Tanaka A, et al. Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int. 2009;75(8):828–38. https://doi.org/10.1038/ki.2008.661.

    Article  CAS  PubMed  Google Scholar 

  18. Apfel RE. Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br J Cancer Suppl. 1982;5:140–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Maisonhaute E, Prado C, White PC, Compton RG. Surface acoustic cavitation understood via nanosecond electrochemistry. Part III: shear stress in ultrasonic cleaning. Ultrason Sonochem. 2002;9(6):297–303.

    Article  CAS  PubMed  Google Scholar 

  20. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65(6):2003–17. https://doi.org/10.1111/j.1523-1755.2004.00621.x.

    Article  CAS  PubMed  Google Scholar 

  21. Sun D, Wang Y, Liu C, Zhou X, Li X, Xiao A. Effects of nitric oxide on renal interstitial fibrosis in rats with unilateral ureteral obstruction. Life Sci. 2012;90(23–24):900–9. https://doi.org/10.1016/j.lfs.2012.04.018.

    Article  CAS  PubMed  Google Scholar 

  22. Leonard EC, Friedrich JL, Basile DP. VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am J Physiol Ren Physiol. 2008;295(6):F1648-57. https://doi.org/10.1152/ajprenal.00099.2008.

    Article  CAS  Google Scholar 

  23. Breen EC. VEGF in biological control. J Cell Biochem. 2007;102(6):1358–67. https://doi.org/10.1002/jcb.21579.

    Article  CAS  PubMed  Google Scholar 

  24. Matsui K, Nagy-Bojarsky K, Laakkonen P, Krieger S, Mechtler K, Uchida S, et al. Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol. 2003;14(8):1981–9.

    Article  CAS  PubMed  Google Scholar 

  25. Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6(2):107–15. https://doi.org/10.1038/nrneph.2009.213.

    Article  PubMed  Google Scholar 

  26. Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol. 2014;10(1):37–47. https://doi.org/10.1038/nrneph.2013.232.

    Article  CAS  PubMed  Google Scholar 

  27. Bi LY, Zhao DA, Yang DS, Guo JG, Liang B, Zhang RX, et al. Effects of autologous SCF- and G-CSF-mobilized bone marrow stem cells on hypoxia-inducible factor-1 in rats with ischemia-reperfusion renal injury. Genet Mol Res. 2015;14(2):4102–12. https://doi.org/10.4238/2015.April.27.25.

    Article  CAS  PubMed  Google Scholar 

  28. Basile DP, Fredrich K, Chelladurai B, Leonard EC, Parrish AR. Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J Physiol Ren Physiol. 2008;294(4):F928-36. https://doi.org/10.1152/ajprenal.00596.2007.

    Article  CAS  Google Scholar 

  29. Labanaris AP, Kuhn R, Schott GE, Zugor V. Perirenal hematomas induced by extracorporeal shock wave lithotripsy (ESWL). Ther Manag Sci World J. 2007;7:1563–6. https://doi.org/10.1100/tsw.2007.236.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan

    Mai Yoshida, Takashi Nakamichi, Takefumi Mori & Sadayoshi Ito

  2. Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan

    Kenta Ito & Hiroaki Shimokawa

Authors
  1. Mai Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Nakamichi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takefumi Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenta Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroaki Shimokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sadayoshi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Nakamichi.

Ethics declarations

Conflict of interest

The authors have declared that no conflicts of interest exist.

Ethical approval

The protocols of the present study were approved by the ethics committee on animal experiments of Tohoku University (No. 2011-303).

Informed consent

This section is not applicable to this study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yoshida, M., Nakamichi, T., Mori, T. et al. Low-energy extracorporeal shock wave ameliorates ischemic acute kidney injury in rats. Clin Exp Nephrol 23, 597–605 (2019). https://doi.org/10.1007/s10157-019-01689-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-019-01689-7

Keywords

Search

Navigation